ZERVIATE Drug Patent Profile
✉ Email this page to a colleague
When do Zerviate patents expire, and what generic alternatives are available?
Zerviate is a drug marketed by Eyevance and is included in one NDA. There are four patents protecting this drug.
This drug has twenty patent family members in five countries.
The generic ingredient in ZERVIATE is cetirizine hydrochloride. There are thirty-nine drug master file entries for this compound. One hundred and thirty-five suppliers are listed for this compound. Additional details are available on the cetirizine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Zerviate
A generic version of ZERVIATE was approved as cetirizine hydrochloride by TEVA PHARMS on May 27th, 2008.
Summary for ZERVIATE
International Patents: | 20 |
US Patents: | 4 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 97 |
Patent Applications: | 5,219 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for ZERVIATE |
What excipients (inactive ingredients) are in ZERVIATE? | ZERVIATE excipients list |
DailyMed Link: | ZERVIATE at DailyMed |


Anatomical Therapeutic Chemical (ATC) Classes for ZERVIATE
US Patents and Regulatory Information for ZERVIATE
ZERVIATE is protected by four US patents.
Patents protecting ZERVIATE
Ophthalmic formulations of cetirizine and methods of use
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Ophthalmic formulations of cetirizine and methods of use
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Ophthalmic formulations of cetirizine and methods of use
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Ophthalmic formulations of cetirizine and methods of use
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: TREATMENT OF OCULAR ITCHING ASSOCIATED WITH ALLERGIC CONJUNCTIVITIS
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Eyevance | ZERVIATE | cetirizine hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 208694-001 | May 30, 2017 | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | See Plans and Pricing | ||||
Eyevance | ZERVIATE | cetirizine hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 208694-001 | May 30, 2017 | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | Y | See Plans and Pricing | |||
Eyevance | ZERVIATE | cetirizine hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 208694-001 | May 30, 2017 | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | Y | See Plans and Pricing | |||
Eyevance | ZERVIATE | cetirizine hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 208694-001 | May 30, 2017 | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | Y | See Plans and Pricing | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for ZERVIATE
See the table below for patents covering ZERVIATE around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Japan | 2021138760 | セチリジンの眼科用製剤および使用方法 (OPHTHALMOLOGIC PREPARATION OF CETIRIZINE AND METHODS OF USE) | See Plans and Pricing |
Japan | 2018141022 | セチリジンの眼科用製剤および使用方法 (OPHTHALMOLOGIC PREPARATION OF CETIRIZINE AND METHODS OF USE) | See Plans and Pricing |
European Patent Office | 2408453 | FORMULATIONS OPHTALMIQUES DE CÉTIRIZINE ET PROCÉDÉS D'UTILISATION (OPHTHALMIC FORMULATIONS OF CETIRIZINE AND METHODS OF USE) | See Plans and Pricing |
World Intellectual Property Organization (WIPO) | 2011116020 | See Plans and Pricing | |
Japan | 6893573 | See Plans and Pricing | |
Japan | 6033677 | See Plans and Pricing | |
Japan | 2012520882 | See Plans and Pricing | |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for ZERVIATE
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0663828 | C300085 | Netherlands | See Plans and Pricing | PRODUCT NAME: LEVOCETIRIZINE, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT, IN HET BIJZONDER LEVOCETIRINE DIHYDROCHLORIDE; NAT. REGISTRATION NO/DATE: RVG 26770 20011009; FIRST REGISTRATION: DE 49903.00.00 AND 49904.00.00 20010103 |
0058146 | 2001C/045 | Belgium | See Plans and Pricing | PRODUCT NAME: DICHLORHYDRATE DE LEVOCETIRIZINE; NAT RER. NO/DATE: 194 IS 90 F3 20011022; FIRST REG.: DE 49903.00.00 20010103 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |